The use of cetuximab in the continuum of care for patients with metastatic colorectal cancer
The anti-epidermal growth factor receptor (EGFR) monoclonal antibody cetuximab in combination with chemotherapy is the standard of care in the first-line treatment for RAS wild-type metastatic colorectal cancer (mCRC), and it may also be effective in further lines of therapy. After the first-line ce...
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Editorial Office of China Oncology
2020-01-01
|
| Series: | Zhongguo aizheng zazhi |
| Assuntos: | |
| Acceso en liña: | http://www.china-oncology.com/thesisDetails#10.19401/j.cnki.1007-3639.2020.01.008 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|